Physician Assistant · Edina, MN
NPI
1194809400
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6405 France Ave S, Suite W200
Edina, MN, 55435
Phone (952) 924-9005
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
818 services
Medicare patients, 2024
283
Average age 79
Drug cost, 2024
$1.1M
3,995 prescriptions
Company payments, 2025
$2,674
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katherine Moody was code 99214 (office e&m - established), 348 times for 246 patients. In total Katherine Moody billed 818 services in 44 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 348 | 246 | $77.88 | $27K |
| 93000 Electrocardiogram | Office | 110 | 89 | $8.59 | $945 |
| 36415 Venipuncture Blood Collection | Office | 62 | 47 | $8.52 | $528 |
| 80048 Clinical Chemistry | Office | 58 | 40 | $8.29 | $481 |
| 99213 Office E&M - Established | Office | 35 | 34 | $53.34 | $1,867 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 24 | $10.67 | $331 |
| 85027 Blood Count | Office | 28 | 28 | $6.34 | $178 |
| 80053 Clinical Chemistry | Office | 25 | 22 | $10.01 | $250 |
| 84443 Clinical Chemistry | Office | 22 | 18 | $16.46 | $362 |
By year: 2022 $34K for 830 services; 2023 $31K for 826 services; 2024 $34K for 818 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 62 | 47 | $8.52 | $528 |
| 80048 Clinical Chemistry | 58 | 40 | $8.29 | $481 |
| 85027 Blood Count | 28 | 28 | $6.34 | $178 |
| 80053 Clinical Chemistry | 25 | 22 | $10.01 | $250 |
| 84443 Clinical Chemistry | 22 | 18 | $16.46 | $362 |
Medicare prescription drug claims, 2024
In 2024, the drug Katherine Moody prescribed most often to Medicare patients was Eliquis (Apixaban), with 625 prescriptions and refills. In total Katherine Moody wrote 3,995 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 625 | 1,385 | 172 | $785K |
| Metoprolol Succinate Generic | 506 | 1,322 | 176 | $10K |
| Lisinopril Generic | 238 | 608 | 62 | $2,967 |
| Flecainide Acetate Generic | 222 | 593 | 69 | $11K |
| Xarelto Rivaroxaban | 198 | 413 | 52 | $221K |
| Metoprolol Tartrate Generic | 163 | 452 | 59 | $1,642 |
| Amiodarone Hcl Generic | 162 | 323 | 49 | $2,385 |
| Torsemide Generic | 160 | 377 | 57 | $3,220 |
| Furosemide Generic | 148 | 383 | 60 | $1,192 |
| Carvedilol Generic | 134 | 354 | 45 | $2,098 |
| Amlodipine Besylate Generic | 129 | 330 | 43 | $1,336 |
| Atorvastatin Calcium Generic | 112 | 285 | 35 | $1,965 |
| Spironolactone Generic | 95 | 235 | 29 | $875 |
| Losartan Potassium Generic | 92 | 238 | 35 | $2,038 |
| Rosuvastatin Calcium Generic | 74 | 212 | 25 | $1,246 |
Brand drugs: 951 claims; generic drugs: 3,044 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katherine Moody $2,674 ($2,674 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $2,610.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 16 | $2,610 |
| Biotronik Inc. | 1 | $46.1 |
| Impulse Dynamics (USA) Inc. | 1 | $18.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.